Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Incyte
Incyte
Incyte's Jakafi Is Likely A $1 Billion Drug
Seeking Alpha
Thu, 02/28/13 - 11:35 am
Jakafi
Incyte
myelofibrosis
Incyte Earnings: Here’s Why Investors are Happy Now
Wall St. Cheat Sheet
Fri, 02/15/13 - 11:43 am
earnings
Incyte
Incyte Pharmaceuticals Is Primed For A Run
Seeking Alpha
Tue, 02/5/13 - 10:54 am
Incyte
Novartis
Eli Lilly
Jakafi
JPMorgan Healthcare Conference Highlights: Incyte
Motley Fool
Tue, 01/8/13 - 10:23 am
JPMHC 2013
Incyte
13 Biotech Stock Predictions for 2013
TheStreet.com
Wed, 01/2/13 - 12:18 pm
Eisai
Sarepta
Arena Pharmaceuticals
Amarin
Gilead
Biomarin
Onyx
Medivation
Achillion
Incyte
Cell Therapeutics
Celgene
NPS Pharmaceuticals
Aegerion
Roche
Biogen Idec
Ariad Pharmaceuticals
Alexza
Navidea
Aveo
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Mon, 12/24/12 - 10:44 am
Arqule
Array Biopharma
Celldex
Aveo Pharmaceutical
Curis
Exelixis
MorphoSys
Genmab
Novartis
Incyte
Seattle Genetics
YM BioSciences
Hedge Funds Are Buying These 5 Healthcare Stocks With Heavy Short Covering
Seeking Alpha
Sat, 12/1/12 - 09:19 am
Affymax
Genomic Health
Incyte
Infinity Pharmaceuticals
MAP Pharmaceuticals
Incyte Achieves $50 Million Milestone as Oral JAK1/JAK2 Inhibitor Baricitinib Advances into Phase III Development for Rheumatoid Arthritis
Yahoo
Thu, 11/15/12 - 11:06 am
baricitinib
Incyte
JAK inhibitors
Eli Lilly
rheumatoid arthritis
Lilly arthritis drug shows durability in study
Reuters
Tue, 11/13/12 - 05:36 pm
Eli Lilly
baricitinib
Incyte
rheumatoid arthritis
5 Low Risk, High Reward Biotech Stocks
Motley Fool
Fri, 09/28/12 - 10:19 am
Arena Pharmaceuticals
Aeterna Zentaris
Incyte
Jazz Pharmaceuticals
Astex
The Wait Goes On At YM Biosciences
Seeking Alpha
Wed, 09/5/12 - 10:41 am
YM BioSciences
Incyte
Sanofi
JNJ
Novartis
CYT387
Why Incyte Could Be Headed Even Higher
Motley Fool
Sun, 07/15/12 - 11:27 am
Incyte
Mid-Cap Biotech Stocks Accumulated By The World's Largest Money Managers
Seeking Alpha
Sun, 07/15/12 - 11:22 am
Alkermes
Medivation
Cubist Pharmaceuticals
Ariad Pharmaceuticals
Questcor Pharmaceuticals
Arena Pharmaceuticals
Seattle Genetics
Incyte
United Therapeutics
Amarin
ONYX Pharmaceuticals
Pharmacyclics
Human Genome Sciences
Theravance
Incyte Corp Ltd (INCY): Today's Featured Health Care Winner
The Steet
Sat, 07/7/12 - 11:25 am
Incyte
Eli Lilly: A Long-Term Growth Stock
Seeking Alpha
Mon, 07/2/12 - 10:42 am
Eli Lilly
diabetes
Bristol-Myers Squibb
Incyte
Merck
Sanofi
Novo Nordisk
Eli Lilly: New Drug Shows Strong Potential
Seeking Alpha
Fri, 06/22/12 - 09:28 am
Eli Lilly
Incyte
baricitinib
Merck
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
rheumatoid arthritis
New Diabetes Drugs May Push Eli Lilly Higher By 2013
Seeking Alpha
Thu, 06/21/12 - 07:39 am
diabetes
Eli Lilly
Astra Zeneca
Bristol-Myers Squibb
Incyte
linagliptin
Novo Nordisk
JNJ
empagliflozin
Boehringer Ingelheim
Lilly and Incyte's Oral JAK1 and JAK2 Inhibitor
PharmPro
Sat, 06/9/12 - 04:54 pm
Eli Lilly
Incyte
LY3009104
baricitinib
rheumatoid arthritis
Lilly and Incyte's Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
Yahoo
Fri, 06/8/12 - 01:28 pm
Incyte
JAK inhibitors
baricitinib
Eli Lilly
rheumatoid arthritis
Cell Therapeutics' JAK2 Inhibitor Acquisition Is A Smart Pick-Up
Seeking Alpha
Tue, 05/29/12 - 05:09 pm
Cell Therapeutics
JAK inhibitors
Novartis
Pfizer
Onyx
Incyte
pacritinib
Pages
« first
‹ previous
…
10
11
12
13
14
15
16
17
18
next ›
last »